Antibodies to Digoxin for Bipolar Disorder
NCT00550576
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Bipolar Disorder
Interventions
DRUG:
Digibind (Fab)
Sponsor
Rambam Health Care Campus